PRIMIDONE 250 TAB DIN 00563706
Health Canada record
| Active ingredient(s) | PRIMIDONE 250 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | N03AA03 PRIMIDONE |
| Original market date | 31-Dec-1982 |
| Current status date | 12-Aug-1999 |
| Source | Health Canada DPD |
Establishment licence of the holder
Pro Doc Limitée — licence 100182, currently licensed, last inspection rating C (2025-08-11).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing PRIMIDONE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00396761 | PRIMIDONE | AA PHARMA INC | Tablet | PRIMIDONE 250 MG | Marketed |
| 00399310 | PRIMIDONE | AA PHARMA INC | Tablet | PRIMIDONE 125 MG | Marketed |
| 02042355 | MYSOLINE 250MG TAB | ELAN PHARMACEUTICALS INC | Tablet | PRIMIDONE 250 MG | Cancelled Post Market |
| 02042363 | MYSOLINE PEDIATRIC CHEWABLE TABLETS 125MG | ELAN PHARMACEUTICALS INC | Tablet | PRIMIDONE 125 MG | Cancelled Post Market |
| 00002631 | MYSOLINE PRIMIDONE TABLETS 250MG | AYERST VETERINARY LABORATORIES | Tablet | PRIMIDONE 250 MG | Cancelled Post Market |
| 00002623 | MYSOLINE TAB 125MG | AYERST LABORATORIES | Tablet | PRIMIDONE 125 MG | Cancelled Post Market |
| 00563714 | PRIMIDONE 125 TAB | PRO DOC LIMITEE | Tablet | PRIMIDONE 125 MG | Cancelled Post Market |
| 00576700 | SERTAN TAB 125MG | PHARMASCIENCE INC | Tablet | PRIMIDONE 125 MG | Cancelled Post Market |
| 00576719 | SERTAN TAB 250MG | PHARMASCIENCE INC | Tablet | PRIMIDONE 250 MG | Cancelled Post Market |
International API supply for PRIMIDONE
4 valid EDQM Certificates of Suitability from 4 holders. 5 active FDA Drug Master Files.
Request a quote for PRIMIDONE 250 TAB